Results. Inter-observer variability was 2.3 6 0.9%, 1.9 6 0.8% and 3.0 6 2.3% in, respectively, controls, moderate and severe CKD. The mean R2* of the outer (more cortical) layers was significantly higher in CKD, suggesting lower cortical oxygenation as compared with controls. In CKD patients, the response to furosemide was blunted in the inner (more medullary) layers, and the R2* slope was flatter. In multivariable regression analysis, the R2* slope correlated positively with estimated glomerular filtration rate (eGFR) in patients with an eGFR <90 mL/ min/1.73 m 2 (P < 0.001). Conclusions. Using the new TLCO method, we confirm the hypothesis that renal cortical oxygenation is reduced in CKD in humans, and that the level of cortical oxygenation correlates with CKD severity.
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I N T R O D U C T I O N
Chronic kidney disease (CKD) has become a major public health problem with a global prevalence in the general population of $10% [1] . Renal hypoxia may play a role in the development and progression of CKD, as proposed by the chronic hypoxia model [2] . Animal studies measuring intra-renal pO 2 with microelectrodes have supported this hypothesis [3, 4] . In humans, blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) offers the possibility to measure tissue oxygenation non-invasively [5, 6] . Surprisingly, however, BOLD-MRI studies have not consistently found that there is renal tissue hypoxia in patients suffering from CKD [7] [8] [9] [10] . Thus, the role of renal tissue hypoxia in the pathogenesis of CKD progression in humans remains uncertain. Animal studies have reported linear relationships between directly measured renal pO 2 values and R2* (i.e. the lower the tissue pO 2 , the higher the R2*), thus supporting the hypothesis that BOLD-MRI measures tissue pO 2 with a reasonable accuracy [5, [11] [12] [13] [14] . Therefore, the uncertainty may be partly related to the methods used to analyse BOLD-MRI data. We have previously shown that the classical region of interest (ROI) technique, based on manual placement of circle-shaped ROIs in the cortex and medulla, has a high inter-observer variability in CKD due to loss of cortico-medullary differentiation [15] . In that same article, we proposed a new semi-automatic technique, called 'concentric objects' (CO) or onion peel technique. This technique divides the kidney parenchyma in six layers of equal thickness and reports the mean R2* value of each layer. Notably, the CO technique had very low inter-observer variability. When applied to a small number of subjects, it also suggested that R2* values in the outer layers were higher in CKD patients as compared with healthy controls. However, cysts had to be suppressed manually, the technique could not be applied to nonoval-shaped kidneys and the relatively limited number of layers lacked precision. Finally, the CO technique only reported the mean R2* values of each layer, without analysing the relative changes in mean R2* from superficial to deeper layers of the renal parenchyma. We have therefore improved the technique by developing an automated, twelve-layer CO technique (called the TLCO technique) to analyse BOLD images. In this article, we describe this new technique and provide data on its interobserver reproducibility. Based on a large cohort, we have also assessed whether there are indeed differences in R2* values between CKD patients as compared with normotensive and hypertensive controls.
M A T E R I A L S A N D M E T H O D S

Participants
All the individuals included in this study are part of the LauBOLD cohort. LauBOLD is a cohort evaluating the prognostic value of renal tissue oxygenation on the progression of kidney diseases, as previously described in more detail [7] . In brief, adult patients with CKD stages 1-5, irrespective of cause, were recruited at our nephrology outpatient clinic, as well as hypertensive individuals without CKD. CKD was defined as the presence of structural kidney damage, an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m 2 or albuminuria >300 mg/24 h for at least 3 months [16] . The following criteria applied to healthy volunteers: no drug intake, absence of kidney abnormalities at screening renal ultrasound, eGFR !60 mL/ min/1.73 m 2 and absence of (micro) albuminuria or hypertension. MR scans were exclusively performed for this study, and not for medical reasons.
Reproducibility study. For this part of the study, 20 healthy controls, 18 CKD patients with mild to moderate CKD (eGFR !45 mL/min/1.73 m 2 according to the CKD-EPI formula) and 14 CKD patients with more severe CKD (eGFR <45 mL/min/ 1.73 m 2 ) were randomly selected from the LauBOLD cohort. Their scans were analysed by two experienced observers who were unaware of the CKD stage.
Comparison study. In the second part of the study, differences in R2* between CKD patients, hypertensives and normotensive controls were analysed in all participants of the LauBOLD cohort with BOLD images of sufficient quality (i.e. without substantial movement or other artefacts).
The study was approved by the local ethical committee (Ethical Committee of the Canton de Vaud, Switzerland) and written informed consent was obtained from all individuals.
Study visit
Every participant followed the same hydration protocol (water intake of 3 mL/kg at 8 a.m. at home, followed by 1 mL/ kg/h on the day of the MRI exam). A 24 h urine collection on the day preceding the BOLD-MRI examination was performed to verify salt intake. All medication intake was continued on the day of the MRI exam. BOLD-MRI was performed between 1 and 2 p.m. All participants underwent a BOLD-MRI before and 15 min after the injection of 20 mg of furosemide (Lasix V R , Sanofi-Aventis, Paris, France) during this time slot. No contrast agents were administered.
BOLD-MRI measures R2* (defined as 1/T2*) for each voxel of a sample. The R2* is expressed in s À1 and is defined as the decay rate (1/decay time) of the transversal component of the macroscopic magnetization of the corresponding voxel, such that M ¼ M0 e (ÀR2 * t) . This parameter is influenced by any kind of inhomogeneity in the local static magnetic field, in particular by the effect of deoxyhemoglobin, which has a strong positive magnetic susceptibility. The susceptibility difference between deoxyhemoglobin and surrounding tissues will generate intravoxel B-field inhomogeneities. As such, the decay rate R2* will be enhanced when the local deoxyhaemoglobin concentration is increased. This is the case when renal tissue oxygenation is low, assuming that blood pO 2 is in equilibrium with the surrounding tissue pO 2 .
MR images were acquired using four coronal slices on a 3T-whole-body MR system (Magnetom Prisma, Siemens Medical Systems, Erlangen, Germany), as described previously [7] . Twelve T2*-weighted images were collected for each coronal slice within a single breath-hold of 16 
Analysis of images with the TLCO technique
The TLCO technique was implemented with Matlab 7.11 (The MathWorks Inc., Natick, MA, USA). R2* maps were calculated on a voxel by voxel basis, using a linear least squares fit of the logarithm of the signal. In each selected coronal slice, the circumference of the renal parenchyma was drawn manually. The outer and inner boundaries of the kidneys were visually identified by the investigator. After manual definition of the parenchyma, a locally programmed automatic algorithm divided the parenchyma into 12 concentric areas of equal thickness as shown in Figure 1 . These areas were called the concentric objects (COs), each cover a set of pixels with a constant (range of) depth inside the kidney. In certain cases, air in the intestines created magnetic susceptibility artefacts. To account for this, large deviations from the fitted exponential were excluded from the analysis by applying a mask on the image that retained only the voxels for which the mean of the square of the relative errors between the fitted exponential and the data points were smaller than 10% (¼ 0.1). In addition, voxels with R2* values below 10 s À1 or above 50 s À1 were excluded, since these values are not in the range of significance for the renal parenchyma and most likely corresponded to cysts or artefacts. Concerning large cysts or tumours, the algorithm that draws the COs was programmed to neglect their presence ( Figure 1 ).
The COs were also extended in three dimensions. The set of voxels present in one layer, and thus at a constant (range of) depth in the renal parenchyma of all (four) slices of the
The TLCO technique. The outer border (in red) and inner border (in blue) of the renal parenchyma are drawn manually on anatomical templates (A and D); corresponding R2* maps are shown in the middle (B and E). After importation in Matlab, an automatic procedure divides the selected renal parenchyma into 12 layers of equal thickness (C); voxels with R2* <10 or >50 s À1 are suppressed, as well as voxels with badly exponential-fitted signal (dark blue dots). Cysts are also suppressed (F).
kidney was called a CO3D (CO in 3 dimensions), as shown in Figure 2 .
By averaging the R2* values in each of the 12 CO3Ds, the mean R2* of each layer was obtained. The mean R2* values of all 12 CO3Ds at increasing depth can be plotted as a curve, and was called the R2* radial profile (an example for one participant is shown in Figure 3A) . The x-axis of this curve represents the percent of relative depth (ranging from 0% to 100%) and the yaxis represents the mean R2* of each CO3D. The superficial CO3Ds (cortex side) are shown on the left of the graph, with the inner CO3Ds (medulla side) on the right.
For each kidney, the R2* radial profile was calculated both before and 15 min after the injection of furosemide. A third curve, defined as the 'response profile', corresponded to the prefurosemide curve minus the post-furosemide curve and represented the absolute furosemide-induced change in R2*, as a function of the depth ( Figure 3B ). A high difference corresponded to a large decrease of R2* and presumably an increase in oxygenation.
The shape and slope of the R2* radial profile
The radial R2* curves were almost always linear between its deepest point and the next four points to its right. Five points were therefore selected in order to measure the slope of the curve within this linear section: the minimum of the radial profile and the four next points to its right. The R2* radial profiles were shifted down to the x-axis, such that the value of the third point was 0 for every curve. This shift permitted a comparison of the shapes of the curves, instead of their absolutes values (Supplementary data, Figure S1 ). In this way, the change in R2* from superficial to profound layers could be compared, independently of its absolute values. The larger the difference in R2* between the lowest and highest point of the shifted R2* profile, the steeper the slope, and thus the larger the presumed oxygenation difference between outer (more cortical) and inner (mainly medullary) layers. The slope of each kidney R2* profile was expressed as the change in Hertz per percentage change of depth.
Statistical analysis
Statistical analysis was performed with STATA 12.0 (StataCorp, College Station, TX, USA). Quantitative values were R2* values of each of 12 layers of the kidneys were analysed separately by group (control, CKD 1-3a and CKD 3b-5). The coefficient of variation, Lin's correlation coefficient and BlantAltman curves were used to assess inter-observer variability of the mean R2* values of each layer (CO3D), and of each curve (see Supplementary data for more details).
In the comparison study, between-group differences of R2* values were compared using two-tailed t-tests.
The regression coefficient b of the R2* slope of each kidney was calculated with the linear least square regression technique; assumptions were checked for this model. In order to study the relationship between the slope and eGFR, the mean slope of each individual was calculated, with the presumption that eGFR represents the sum of the filtration rate of both kidneys. Multivariate linear regression analysis was performed to explore the associations of clinical variables with the R2* slope (dependent variable). Unadjusted analyses were performed first, followed by multivariable analyses integrating all variables associated with the slope in unadjusted analysis. We further explored the association of the R2* slope with eGFR, by stratifying eGFR in groups of either <90 or !90 mL/min/1.73 m 2 . This was performed due to the relationship between R2* slope and eGFR not being purely linear, with a visually observed change in the approximate slope at $90 mL/min/ 1.73 m 2 . For all analyses, a P-value <0.05 was considered as significant.
R E S U L T S
Inter-observer variability study
Clinical and laboratory characteristics of the 52 individuals who participated in this part of the study are shown in Table 1 . For the TLCO technique, a low inter-observer variability was found, with mean coefficients of variation (CVs) of 2.2 6 1.5, 2.0 6 1.7 and 3.1 6 2.9%, respectively, in the healthy, mild CKD and severe CKD groups (Table 2 ). Lin's correlation coefficient was systematically above 85%, except for the two deepest layers. Similar results were found after furosemide (Supplementary data, Table S1 ).
Regarding the variability of the slope of the R2* curve, the mean CV varied between 15.9 and 26.8%, and Lin's correlation coefficient between 78 and 80% in the three groups ( Table 2 ). The Bland-Altman plot of the measured slopes is shown in Supplementary data, Figure S2 . The mean difference of the slopes between both observers was 0.0033 s À1 /(% of depth) and was not significant (P ¼ 0.1).
Comparison study
Of the 214 LauBOLD participants, seven were excluded due to poor image quality. Clinical characteristics of the remaining 207 participants are shown in Table 1 . Details on drug intake are provided in Supplementary data, Table S2 .
The radial R2* profiles of the control, hypertensive and CKD groups of the entire LauBOLD cohort are shown in Figure 4 . There was no significant difference between the normotensive and the hypertensive control group in the R2* values of any of the 12 layers. However, the mean R2* of the outer layers of the CKD group was significantly higher than hypertensive and normotensive controls, suggesting lower oxygenation, whereas R2* values of layer 10 and 11 were significantly lower than normotensive controls. Absolute furosemide-induced changes in R2* were significantly smaller in CKD patients as compared with hyper-or normotensive controls ( Figure 5 ). Shifted R2* profiles (i.e. shifting down to the x-axis of the R2* profile, such that the point with the lowest R2* value was 0 for every curve and only relative differences are identified) are shown in Figure 6 according to four eGFR categories, for all LauBOLD participants taken together. In all categories, R2* increased at increasing depth, suggesting lower oxygenation in more medullary zones. The increase in R2* was highest in members of the highest eGFR category. The corresponding R2* slope was therefore the steepest in the highest eGFR category, with the slopes of the four categories being 0.032, 0.047, 0.070 and 0.088 s À1 /depth percentage (P-value for trend < 0.001). The slope was less steep in CKD patients as compared with hyper or normotensive controls (Supplementary data, Figure S3 ).
The continuous association between the radial profile-slope and the eGFR, with all groups combined, is graphically illustrated in Figure 7 .
In univariate linear regression analysis, the clinical variables of female gender, eGFR and haemoglobin were positively associated with the R2* slope (outcome variable), whereas age, having diabetes and the daily intake of angiotensin 2 receptor blockers (n ¼ 66) or thiazide diuretics (n ¼ 37) were negatively associated with the R2* slope ( Table 3 ). The number of patients taking daily loop diuretics was low (n ¼ 19), and this variable was therefore not included in the model. In multivariate analysis, adjusted for all variables that reached a P-value <0.10 in univariate analysis, only eGFR and female gender remained (positively) associated with the R2* slope, whereas chronic thiazide diuretic intake correlated negatively.
Graphically, the relationship between the R2* slope and eGFR was not linear, with a change in slope at an eGFR around 90 mL/min/1.73 m 2 . We therefore also stratified the analysis by eGFR !90 and <90 mL/min/1.73 m 
D I S C U S S I O N
Taken together, the present study shows that the inter-observer variability of the new TLCO method is small, indicating that it is largely observer-independent, even in cases of severe CKD. In addition, we demonstrate that the R2* profiles obtained with this technique differ significantly between CKD patients and hypertensive or healthy controls. R2* values of the outer (more cortical) layers are significantly higher in CKD patients, suggesting a lower cortical oxygenation. Furosemide-induced changes FIGURE 4: Averaged R2* radial profiles of all normotensive controls, hypertensive controls and patients with CKD. R2* values of the outer layers were significantly higher in the CKD group, suggesting lower cortical oxygenation, whereas R2* values of the inner layers were higher in normotensive controls as compared with CKD patients. Student's t-tests were used to compare R2* values of each layer; *P < 0.05. 
in R2* are also highly reproducible, and can be analysed layerby-layer. In our cohort, smaller furosemide-induced changes are observed in the CKD group, especially in the deeper layers, indicating a lower furosemide-induced change in active sodium transport as compared with healthy or hypertensive participants. Finally, a new concept that takes into account the rate of change in R2* (the slope) from the outer to the inner border of renal parenchyma is introduced to analyse BOLD-MRI results. This analysis is less reproducible, but shows that the slope correlates strongly and positively with the eGFR, such that the higher the eGFR, the steeper the slope of the associated R2* change. A multitude of techniques have been used to analyse BOLD-MRI to date, yet all have specific shortcomings. For instance, the fractional tissue hypoxia-method reports the percentage of R2* values above 30 s À1 [17] . This is an arbitrary threshold that cannot be applied to scanners of different field strengths or different populations. The compartmental method assumes that the R2* voxels follow a more Gaussian distribution in the cortex, and a gamma distribution in the medulla. Based on this assumption, an algorithm has been developed to decide whether a voxel belongs to the cortex or medulla [18] . However, this FIGURE 7: Mean slope factor across different levels of eGFR. The higher the eGFR, the higher the slope factor. A plateau of the slope factor was reached above 90 mL/min/1.73 m 2 .
FIGURE 5: Absolute furosemide-induced changes in R2* (R2* profile), according to group.
FIGURE 6: Shifted R2* radial profile at decreasing levels of eGFR, for all LauBOLD participants taken together. The largest increase in R2* over layers at increasing depth (corresponding to the steepest slope) was seen in the highest eGFR category, suggesting that the change in oxygenation from cortex to medulla was the largest in the highest eGFR group. algorithm depends on the absolute values of R2*, and to date, it is uncertain whether this algorithm is reliable in CKD. The classical ROI technique remains the most frequently used analytic approach of BOLD-MRI images, yet this method is prone to subjectivity in individuals with poor cortico-medullary differentiation [15] . Recently, Thacker et al. used large cortical ROIs and the entire renal parenchyma to analyse BOLD images; the method has a high inter-observer agreement, but does not provide detailed layer by layer information as obtained with the TLCO technique [19] . The lack of consensus on how to analyse BOLD-MRI images is probably one of the reasons that BOLD-MRI has not been regularly used in clinical practice. Therefore, a widely accepted procedure is needed. In our opinion, the TLCO technique overcomes most of the limitations mentioned above. Firstly, the TLCO technique is largely observer-independent, as demonstrated in this study. Secondly, the technique takes into account almost the entire surface of the renal parenchyma, and integrates geometrical information. Hence, the method is more sensitive to small differences in R2* than the ROI technique. This is illustrated in our study by the fact that the R2* levels of the outer layers were higher (suggesting lower oxygenation) in CKD patients than controls. These results are in contrast to a previous study that also included participants to the LauBOLD cohort but used the ROI technique, in which no difference in R2* was found between CKD patients, normo-and hypertensive controls [7] . Thirdly, the TLCO technique provides unique information on the renal response to external stimuli at different renal depths. This technique is therefore a powerful tool to study the effects of medication on renal oxygenation as estimated with BOLD-MRI [20] . The response to furosemide illustrates this potential. As expected, smaller decreases in R2* in response to furosemide were found in the CKD group. This is generally attributed to the lower change in furosemide-induced oxygen-consuming active sodium transport in CKD patients due to a reduced number of functioning nephrons [7, 21] .
Quantitative analysis of BOLD-MRI remains limited due to lack of direct validation with oxygen sensors in humans. Additionally, R2* values are influenced by multiple external and internal factors such as hydration status [22] , dietary sodium intake [23] , and changes in vascular and tubular volume fraction [24] . A method that focuses less on the mean R2* values and more on its intra-compartmental distribution can overcome this limitation. As such, the analysis of the R2* slope offers a new way to analyse relative intra-kidney differences in R2* values. We observed that the radial R2* curves increased linearly between the third and seventh layer, suggesting a sharp decrease in oxygenation at this point, as previously reported in animal studies [4, 25, 26] . By offsetting the R2* value of the deepest point of the curve (in general at the third layer) to 0, the slope of this linear part can be assessed, and expressed as regression coefficient b, corresponding to the change in s À1 per percentage change of depth.
The slope of this linear fraction was flatter in CKD patients, and correlated strongly and positively with an eGFR below <90 mL/min/1.73 m 2 , but not in cases when eGFR was !90 mL/ min/1.73 m 2 . This may possibly be explained as follows: in healthy kidneys, there is a large difference between cortical (high) and medullary (low) oxygenation, likely due to the high degree of oxygen-consuming active transport in the medulla. In CKD, cortical ischaemia increases, whereas active transport decreases in the medulla due to lack of functional tubuli, leading to a smaller difference between cortical and medullary oxygenation, and thus a less steep slope. On theoretical grounds, the R2* slope can therefore be seen as a marker of cortico-medullary differentiation. It also provides a parameter that can be compared between subjects, different centres and possibly even different field strengths. Of note, the slope factor is less observerindependent than the R2* curve. This is most likely explained by the fact that the slope is directly influenced by the manual placement of the inner border. Further improvement is therefore needed. Ideally, the placement of the inner border should not rely on the human eye but become an observerindependent, automatic procedure.
Another limitation of the TLCO technique remains its inability to differentiate between cortex and medulla. Integration of the R2* response to furosemide into the algorithm, and blood flow-based MRI techniques such as arterial spin labelling, could potentially help to overcome this shortcoming in the future. Finally, the absolute thickness of the renal parenchyma is not integrated in the analysis, so between-layer differences are relative and cannot be easily translated into changes in R2* values per mm of renal tissue parenchyma.
In conclusion, the TLCO technique is an observerindependent method to analyse BOLD-MRI images. This technique provides detailed layer-by-layer information on the R2* values and hence on the level of oxygenation within the kidneys and a way to measure any drug-induced changes in that oxygenation. As such, a higher R2* value (indicating hypoxia) was found in the cortical layers of CKD patients. The furosemide-induced decrease in R2* was smaller as compared with controls and hypertensive persons, indicating a reduced renal response to furosemide in CKD. The TLCO technique also provides the unique opportunity to calculate a new parameter-the slope factor-that does not solely rely on mean R2* values, but merely on intra-renal geometrical distribution and change. This slope factor may be an indirect index of the cortico-medullary differentiation, though this conjecture needs validation in biopsy studies. Whether this slope factor has prognostic potential and adds valuable information to the prediction of renal function decline on top of classical risk markers will also need further study.
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